$PETV
PetVivo Holdings, Inc.

2022 Q3 Form 10-Q Financial Statement

#000149315222022105 Filed on August 11, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $223.3K $58.17K $55.46K
YoY Change 4383.53% 1303.47% 950.38%
Cost Of Revenue $148.2K $53.02K $97.11K
YoY Change 949.69% 838.26%
Gross Profit $75.12K $5.154K -$41.65K
YoY Change 1408.45% -668.87% 721.5%
Gross Profit Margin 33.64% 8.86% -75.1%
Selling, General & Admin $2.054M $1.900M $1.548M
YoY Change 107.1% 399.0% 359.49%
% of Gross Profit 2734.66% 36856.64%
Research & Development $140.4K $71.66K $187.2K
YoY Change 20.63% -47.67% 175.47%
% of Gross Profit 186.88% 1390.3%
Depreciation & Amortization $28.72K $27.55K $21.98K
YoY Change 103.83% 102.61% 61.03%
% of Gross Profit 38.23% 534.59%
Operating Expenses $2.195M $1.971M $1.735M
YoY Change 98.02% 280.83% 463.64%
Operating Profit -$2.120M -$1.966M -$1.777M
YoY Change 92.1% 279.17% 467.82%
Interest Expense $7.980K $670.00 $240.00
YoY Change -476.42% -117.68% -102.65%
% of Operating Profit
Other Income/Expense, Net $7.979K $665.00
YoY Change -476.72% -97.62%
Pretax Income -$2.112M -$1.965M -$1.777M
YoY Change 91.01% 300.59% 450.05%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$2.112M -$1.965M -$1.777M
YoY Change 91.01% 300.59% 450.05%
Net Earnings / Revenue -945.71% -3378.53% -3203.68%
Basic Earnings Per Share -$0.21 -$0.20
Diluted Earnings Per Share -$210.0K -$196.8K -$182.0K
COMMON SHARES
Basic Shares Outstanding 10.04M shares 9.988M shares
Diluted Shares Outstanding 10.05M shares 9.988M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.337M $4.379M $6.107M
YoY Change -73.49% 2960.29% 25798.35%
Cash & Equivalents $2.337M $4.379M $6.107M
Short-Term Investments
Other Short-Term Assets $612.1K $504.8K $547.7K
YoY Change -1.08% 392.27% 343.16%
Inventory $305.0K $180.9K $98.31K
Prepaid Expenses
Receivables $129.1K $4.677K $2.596K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $3.383M $5.069M $6.755M
YoY Change -64.43% 1963.69% 4490.83%
LONG-TERM ASSETS
Property, Plant & Equipment $341.1K $311.1K $311.5K
YoY Change -3.1% -11.95% -16.21%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $12.83K $12.83K $12.83K
YoY Change 56.46% 56.46% 56.46%
Other Assets $0.00
YoY Change -100.0%
Total Long-Term Assets $667.5K $654.5K $671.9K
YoY Change 65.55% -6.39% -2.35%
TOTAL ASSETS
Total Short-Term Assets $3.383M $5.069M $6.755M
Total Long-Term Assets $667.5K $654.5K $671.9K
Total Assets $4.051M $5.724M $7.427M
YoY Change -59.14% 505.79% 789.23%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $422.1K $477.9K $323.4K
YoY Change -46.27% -47.23% -66.42%
Accrued Expenses $765.1K $676.6K $784.4K
YoY Change 82.27% 110.79% 1137.38%
Deferred Revenue
YoY Change
Short-Term Debt $6.740K $6.640K
YoY Change 5.97% -82.46%
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $1.254M $1.221M $1.173M
YoY Change 2.96% -8.95% -16.48%
LONG-TERM LIABILITIES
Long-Term Debt $23.87K $25.55K $27.20K
YoY Change -21.58% -86.96% -86.12%
Other Long-Term Liabilities $209.8K $224.9K $239.9K
YoY Change 78.24% 80.69% 82.89%
Total Long-Term Liabilities $233.7K $250.4K $267.1K
YoY Change 57.72% -21.86% -18.36%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.254M $1.221M $1.173M
Total Long-Term Liabilities $233.7K $250.4K $267.1K
Total Liabilities $1.487M $1.471M $1.441M
YoY Change 8.9% -11.44% -16.83%
SHAREHOLDERS EQUITY
Retained Earnings -$67.20M -$65.09M -$63.13M
YoY Change
Common Stock $10.10K $9.988K $9.988K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.563M $4.253M $5.987M
YoY Change
Total Liabilities & Shareholders Equity $4.051M $5.724M $7.427M
YoY Change -59.14% 505.79% 789.23%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$2.112M -$1.965M -$1.777M
YoY Change 91.01% 300.59% 450.05%
Depreciation, Depletion And Amortization $28.72K $27.55K $21.98K
YoY Change 103.83% 102.61% 61.03%
Cash From Operating Activities -$2.048M -$1.702M -$1.369M
YoY Change 88.87% 565.09% -14247.52%
INVESTING ACTIVITIES
Capital Expenditures -$58.67K $24.90K -$72.12K
YoY Change 94.59% 3656.25%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$58.67K -$24.90K -$72.12K
YoY Change 94.59% 310.64% 2905.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change -100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 64.97K -$1.563K -5.310K
YoY Change -99.34% -100.41% -97.53%
NET CHANGE
Cash From Operating Activities -2.048M -$1.702M -1.369M
Cash From Investing Activities -58.67K -$24.90K -72.12K
Cash From Financing Activities 64.97K -$1.563K -5.310K
Net Change In Cash -2.042M -$1.728M -1.447M
YoY Change -123.54% -1546.09% 597.71%
FREE CASH FLOW
Cash From Operating Activities -$2.048M -$1.702M -$1.369M
Capital Expenditures -$58.67K $24.90K -$72.12K
Free Cash Flow -$1.989M -$1.727M -$1.297M
YoY Change 88.71% 574.82% -11284.14%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 PETV Deferred Offering Cost
DeferredOfferingCost
usd
CY2022Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001512922
CY2022Q2 dei Amendment Flag
AmendmentFlag
false
CY2022Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
CY2022Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q2 PETV Forgiveness Of Loan And Accrued Interest
ForgivenessOfLoanAndAccruedInterest
usd
CY2021Q2 PETV Stock Issued During Period Value Warrants Exercises
StockIssuedDuringPeriodValueWarrantsExercises
usd
CY2021Q2 PETV Investor Relations Services Paid In Stock
InvestorRelationsServicesPaidInStock
usd
CY2022Q2 PETV Forgiveness Of Loan And Accrued Interest
ForgivenessOfLoanAndAccruedInterest
usd
CY2021Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
CY2021Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
usd
CY2022Q2 PETV Increase Decrease In Interest Accrued On Convertible Notes Payable
IncreaseDecreaseInInterestAccruedOnConvertibleNotesPayable
usd
CY2022Q2 PETV Increase Decrease In Interest Accrued On Notes Payable Related Party
IncreaseDecreaseInInterestAccruedOnNotesPayableRelatedParty
usd
CY2022Q2 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
usd
CY2022Q2 PETV Increase Decrease In Accrued Expenses
IncreaseDecreaseInAccruedExpenses
usd
CY2021Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2022Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
usd
CY2022Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2022Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
CY2022Q2 PETV Stock Granted For Debt Conversion
StockGrantedForDebtConversion
usd
CY2017Q2 us-gaap Lessor Operating Lease Term Of Contract
LessorOperatingLeaseTermOfContract
P84M
CY2022Q2 PETV Base Rent Payments Included In Prepaid Expenses
BaseRentPaymentsIncludedInPrepaidExpenses
usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
shares
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2022Q2 dei Document Type
DocumentType
10-Q
CY2022Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q2 dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
CY2022Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q2 dei Entity File Number
EntityFileNumber
001-40715
CY2022Q2 dei Entity Registrant Name
EntityRegistrantName
PetVivo Holdings, Inc.
CY2022Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
99-0363559
CY2022Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
5251 Edina Industrial Blvd
CY2022Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Edina
CY2022Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
CY2022Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55439
CY2022Q2 dei City Area Code
CityAreaCode
(952)
CY2022Q2 dei Local Phone Number
LocalPhoneNumber
405-6216
CY2022Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q2 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q2 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022Q2 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022Q2 dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10037578 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4378668 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6106827 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4677 usd
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2596 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
180874 usd
CY2022Q1 us-gaap Inventory Net
InventoryNet
98313 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
504819 usd
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
547664 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
5069038 usd
CY2022Q1 us-gaap Assets Current
AssetsCurrent
6755400 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
311120 usd
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
311549 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
284344 usd
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
299101 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
46225 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
48452 usd
CY2022Q2 us-gaap Security Deposit
SecurityDeposit
12830 usd
CY2022Q1 us-gaap Security Deposit
SecurityDeposit
12830 usd
CY2022Q2 us-gaap Other Assets
OtherAssets
343399 usd
CY2022Q1 us-gaap Other Assets
OtherAssets
360383 usd
CY2022Q2 us-gaap Assets
Assets
5723557 usd
CY2022Q1 us-gaap Assets
Assets
7427332 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
477947 usd
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
323384 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
676554 usd
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
784375 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
59492 usd
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
59178 usd
CY2022Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
6639 usd
CY2022Q1 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
6549 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1220632 usd
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1173486 usd
CY2022Q2 PETV Notes Payable And Accrued Interest Non Current
NotesPayableAndAccruedInterestNonCurrent
25548 usd
CY2022Q1 PETV Notes Payable And Accrued Interest Non Current
NotesPayableAndAccruedInterestNonCurrent
27201 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
224852 usd
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
239923 usd
CY2022Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
250400 usd
CY2022Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
267124 usd
CY2022Q2 us-gaap Liabilities
Liabilities
1471032 usd
CY2022Q1 us-gaap Liabilities
Liabilities
1440610 usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9988361 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9988361 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9988361 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9988361 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
9988 usd
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
9988 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
69334386 usd
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
69103155 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-65091849 usd
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-63126421 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
4252525 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
5986722 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5723557 usd
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7427332 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
58174 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4145 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
53020 usd
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5051 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
5154 usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
-906 usd
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
656569 usd
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
49731 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1243022 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
330945 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
71656 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
136937 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
1971247 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
517613 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1966093 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-518519 usd
CY2021Q2 PETV Forgiveness Of Loan And Accrued Interest
ForgivenessOfLoanAndAccruedInterest
31680 usd
CY2022Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
665 usd
CY2021Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3790 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
665 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
27890 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1965428 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-490629 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1965428 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-490629 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9988361 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6946353 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
5986722 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
231231 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1965428 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
4252525 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-896979 usd
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
343098 usd
CY2021Q2 PETV Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
40000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
232658 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
55674 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-490629 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-716178 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1965428 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-490629 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
231231 usd
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
55674 usd
CY2022Q2 PETV Investor Relations Services Paid In Stock
InvestorRelationsServicesPaidInStock
45050 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
27553 usd
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13599 usd
CY2021Q2 PETV Forgiveness Of Loan And Accrued Interest
ForgivenessOfLoanAndAccruedInterest
31680 usd
CY2021Q2 PETV Deferred Offering Cost
DeferredOfferingCost
25190 usd
CY2022Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2205 usd
CY2021Q2 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-21025 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2081 usd
CY2022Q2 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
82561 usd
CY2021Q2 PETV Increase Decrease In Interest Accrued On Convertible Notes Payable
IncreaseDecreaseInInterestAccruedOnConvertibleNotesPayable
192 usd
CY2021Q2 PETV Increase Decrease In Interest Accrued On Notes Payable Related Party
IncreaseDecreaseInInterestAccruedOnNotesPayableRelatedParty
4013 usd
CY2021Q2 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
96 usd
CY2022Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
46742 usd
CY2021Q2 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
182949 usd
CY2021Q2 PETV Increase Decrease In Accrued Expenses
IncreaseDecreaseInAccruedExpenses
14090 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1701699 usd
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-255861 usd
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
24897 usd
CY2021Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
6063 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-24897 usd
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6063 usd
CY2021Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
343098 usd
CY2021Q2 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
40000 usd
CY2022Q2 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1563 usd
CY2021Q2 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1668 usd
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1563 usd
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
381430 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1728159 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
119506 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6106827 usd
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
23578 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4378668 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
143084 usd
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
690 usd
CY2021Q2 us-gaap Interest Paid Net
InterestPaidNet
3889 usd
CY2021Q2 PETV Stock Granted For Debt Conversion
StockGrantedForDebtConversion
232658 usd
CY2022Q2 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
0 usd
CY2022Q1 us-gaap Fair Value Net Asset Liability
FairValueNetAssetLiability
0 usd
CY2022Q2 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84C_eus-gaap--UseOfEstimates_zbwpgciuIeId" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(D)</i></b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86A_zSiGFyrGm1Kb">Use of Estimates</span></i></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates. Significant estimates include inventory obsolescence, estimated useful lives and potential impairment of property and equipment and intangibles, estimate of fair value of share-based payments and derivative instruments and recorded debt discount, lease assets and liabilities and valuation of deferred tax assets.</span></p>
CY2022Q2 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_zGSS4il743bd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>(F)</i></b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_869_zeajvkalTksi">Concentration-Risk</span></i></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its cash with various financial institutions, which at times may exceed federally insured limits. As of June 30, 2022 and March 31, 2022, the Company did have cash balances in excess of the federally insured limits.</span></p>
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
504819 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
180874 usd
CY2022Q1 us-gaap Inventory Net
InventoryNet
98313 usd
CY2022Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
22989 usd
CY2022Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
11889 usd
CY2022Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
31455 usd
CY2022Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
22960 usd
CY2022Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
126430 usd
CY2022Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
63464 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
180874 usd
CY2022Q1 us-gaap Inventory Net
InventoryNet
98313 usd
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
547664 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
541105 usd
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
516208 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
229985 usd
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
204659 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
311120 usd
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
311549 usd
CY2022Q2 us-gaap Depreciation
Depreciation
25326 usd
CY2021Q2 us-gaap Depreciation
Depreciation
11870 usd
CY2022Q2 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
3870057 usd
CY2022Q1 us-gaap Finite Lived Patents Gross
FiniteLivedPatentsGross
3870057 usd
CY2022Q2 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
26142 usd
CY2022Q1 us-gaap Finite Lived Trademarks Gross
FiniteLivedTrademarksGross
26142 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3896199 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
3896199 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3849974 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3847747 usd
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
46225 usd
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
48452 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2227 usd
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1729 usd
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
344316 usd
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
452137 usd
CY2022Q2 PETV Accrued Lease Termination Expense
AccruedLeaseTerminationExpense
332238 usd
CY2022Q1 PETV Accrued Lease Termination Expense
AccruedLeaseTerminationExpense
332238 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
676554 usd
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
784375 usd
CY2022Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
332000 usd
CY2022Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
332000 usd
CY2020Q1 us-gaap Notes Payable
NotesPayable
42500 usd
CY2020Q1 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.06 pure
CY2022Q2 us-gaap Notes Payable
NotesPayable
32187 usd
CY2022Q1 us-gaap Notes Payable
NotesPayable
33750 usd
CY2022Q2 us-gaap Notes Payable Current
NotesPayableCurrent
6639 usd
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
25548 usd
CY2022Q1 us-gaap Notes Payable Current
NotesPayableCurrent
6549 usd
CY2022Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
27201 usd
CY2022Q2 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
6158 usd
CY2021Q2 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
1729 usd
CY2017Q2 us-gaap Area Of Land
AreaOfLand
3577 sqft
CY2017Q2 PETV Percentage Of Increase In Rent
PercentageOfIncreaseInRent
0.02 pure
CY2017Q2 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
In January 2020, the Company entered into a lease amendment to extend the lease term through November of 2026
CY2020Q1 us-gaap Notes Payable
NotesPayable
42500 usd
CY2022Q2 PETV Base Rent
BaseRent
2205 usd
CY2022Q1 PETV Base Rent
BaseRent
2205 usd
CY2022Q2 us-gaap Payments For Rent
PaymentsForRent
35435 usd
CY2021Q2 us-gaap Payments For Rent
PaymentsForRent
11511 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
59243 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
60588 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
61964 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
63372 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
55102 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
300269 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
15925 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
284344 usd
CY2022Q2 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
the extended lease term to November 2026
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.12 pure
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1701699 usd
CY2022Q2 PETV Operating Lease Liability Gross
OperatingLeaseLiabilityGross
284344 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
284344 usd
CY2022Q2 PETV Operating Lease Rightofuse Current Asset
OperatingLeaseRightofuseCurrentAsset
284344 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
284344 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
59492 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
224852 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
284344 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1965428 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-65091849 usd
CY2021Q2 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
80522 shares
CY2021Q2 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
230000 usd
CY2021Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
2658 usd
CY2021Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
2.89
CY2022Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
182377 usd
CY2021Q2 us-gaap Restricted Stock Expense
RestrictedStockExpense
24846 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2022Q2 PETV Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm
P7Y
CY2022Q2 us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
28023 usd
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
408000 usd
CY2022Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P6Y9M18D
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
2.063 pure
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
2.078 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
2.050 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
2.105 pure
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0149 pure
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0296 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
1.47 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0214 pure
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
195000 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.56
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
195000 shares
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.56
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M24D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
100200 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
90073 shares
CY2022Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.95
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
285073 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.68
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y9M18D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
0 shares
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
195000 shares
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
285073 shares
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.56
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1.68
CY2022Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
0 usd
CY2021Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
0 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
231231 usd
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
55674 usd

Files In Submission

Name View Source Status
0001493152-22-022105-index-headers.html Edgar Link pending
0001493152-22-022105-index.html Edgar Link pending
0001493152-22-022105.txt Edgar Link pending
0001493152-22-022105-xbrl.zip Edgar Link pending
ex10-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
petv-20220630.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
petv-20220630_cal.xml Edgar Link unprocessable
petv-20220630_def.xml Edgar Link unprocessable
petv-20220630_lab.xml Edgar Link unprocessable
petv-20220630_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable